SSI Diagnostica

Hillerød, Denmark Founded: 2016 • Age: 10 yrs Acquired By Adelis Equity Partners
Diagnostic and quality control testing kits are manufactured.

About SSI Diagnostica

SSI Diagnostica is a Healthcare company based in Hillerød (Denmark) founded in 2016, and was acquired by Adelis Equity Partners in March 2016. Diagnostic and quality control testing kits are manufactured. SSI Diagnostica has completed 2 acquisitions, including CTK Biotech and TECHLAB. Its chief executive, as recorded, is Soren Skjold Mogensen. Its focus areas include Traditional Diagnostics.

Company details

SSI Diagnostica was founded in 2016 and is based in Hillerod, Denmark. Operations focus on the production of diagnostic kits and quality control testing solutions within the healthcare sector. These products support laboratory and clinical testing needs. The company is led by CEO Soren Skjold Mogensen, with activities centered on European markets.

Key Metrics

Investors in SSI Diagnostica

SSI Diagnostica has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Adelis Equity.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Adelis Equity is engaged in growing Nordic businesses through partnerships.
adelisequity.comStockholm, Sweden
Premium access

Investor details for SSI Diagnostica

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of SSI Diagnostica

3 people are tracked at SSI Diagnostica (2 in leadership, 1 in team).

NameRoleGroup
Soren Skjold Mogensen
CEOLeadership
Lars Henrik Vejrup Hansen
Group CFOLeadership
Rasmus Aagaard Jensen
Financial ControllerTeam
Premium access

Complete people profiles for SSI Diagnostica

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by SSI Diagnostica

SSI Diagnostica has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CTK Biotech and TECHLAB.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Rapid diagnostic tests for gastrointestinal diseases are developed and manufactured.
techlab.comUnited States1989Aug 2022••••
Lateral flow immunoassay and ELISA kits for clinical diagnostics
ctkbiotech.comSan Diego, United States1997Aug 2020••••
Premium access

Complete acquisition details for SSI Diagnostica

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of SSI Diagnostica

4 dated milestones of SSI Diagnostica across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded SSI Diagnostica is founded.
  2. Exit Acquired by Adelis Equity Partners.
  3. Acquisition Acquires CTK Biotech.
  4. Acquisition Acquires TECHLAB.

Web traffic of SSI Diagnostica

The website of SSI Diagnostica (ssidiagnostica.com) receives about 3.1K visits a month and ranks #3,699,299 among all websites worldwide, #4,746 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    3.1K

    ▼ 37.9% vs previous month

  • Unique visitors
    2.1K

    per month

  • Global rank
    #3,699,299

    among all websites

  • Category rank
    #4,746

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with SSI Diagnostica. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
revmedconnect.com
revmedconnect.com
100%
#771,336–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about SSI Diagnostica

SSI Diagnostica was founded in 2016.

SSI Diagnostica is headquartered in Hillerød, Denmark. It is registered at Hillerød, Capital Region, Denmark.

Soren Skjold Mogensen is the CEO of SSI Diagnostica, as recorded in our data.

Annual revenue of SSI Diagnostica is $44.77M as on Dec 31, 2022.

SSI Diagnostica was founded in 2016 and is based in Hillerod, Denmark. Operations focus on the production of diagnostic kits and quality control testing solutions within the healthcare sector. These products support laboratory and clinical testing needs. The company is led by CEO Soren Skjold Mogensen, with activities centered on European markets.

SSI Diagnostica has made 2 acquisitions, including CTK Biotech, and TECHLAB.

SSI Diagnostica has 1 investor. Key investors include Adelis Equity.

Yes. SSI Diagnostica was acquired by Adelis Equity Partners in March 2016.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available